← FDA Drug Approvals (Drugs@FDA)

NAFCILLIN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ISTITUTO BIO ITA SPA · Approved 2011-04-20

Drug application

FDA Application #

ANDA090005

Application type

Abbreviated New Drug Application (Generic)

Brand name

NAFCILLIN SODIUM

Generic name

NAFCILLIN SODIUM

Active ingredients

NAFCILLIN SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ISTITUTO BIO ITA SPA

Manufacturer

Athenex Pharmaceutical Division, LLC.

First approval

2011-04-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown